E. Faecalis has been observed to slowly evolve immunity to a drug which targets this organelle by binding to domain V, those drugs are oxazolidinones. A Fungus of the genus Fusidium produce a different drug which targets this structure. The antifungal cycloheximide functions by targeting this structure. One method of targeting this structure does so by preventing the turnover of EF-G. Many drugs which target this structur
E. Faecalis has been observed to slowly evolve immunity to a drug which targets this organelle by binding to domain V, those drugs are oxazolidinones. A Fungus of the genus Fusidium produce a different drug which targets this structure. The antifungal cycloheximide functions by targeting this structure. One method of targeting this structure does so by preventing the turnover of EF-G. Many drugs which target this structure, including pleuromutilin and macrolides, do so by inhibiting peptidyl transferase. Tetracyclines inhibit this structure by blocking the attachment of aminoacyl tRNA to the A site. Drugs that target this structure usually target either the 50S or 30S subunits. For 10 points, name this structure, which is targeted to inhibit protein synthesis.